Related Experiment Video

Updated: Sep 25, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Multiple system atrophy

G K Wenning1, F Geser

  • 1Department of Neurology, University Hospital Innsbruck, Austria. gregor.wenning@uibk.ac.at

Revue Neurologique
|May 30, 2003
PubMed

Insights

Multiple system atrophy (MSA) is a rare neurodegenerative disease affecting people in their fifties. Early diagnosis of autonomic dysfunction is crucial for effective treatment, despite limited options for motor symptoms.

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Background:

  • Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder with a mean survival of 9 years.
  • Clinical presentation includes autonomic/urogenital failure, parkinsonism (MSA-P), or cerebellar ataxia (MSA-C).
  • Pathology involves neuronal degeneration and alpha-synuclein aggregates in glial cytoplasmic inclusions.

Purpose of the Study:

  • To highlight the clinical and pathological characteristics of MSA.
  • To emphasize the importance of early diagnosis and effective treatment of autonomic dysfunction.
  • To underscore the need for further research into MSA etiology, pathogenesis, diagnosis, and therapeutics.

Main Methods:

  • Clinical case review and pathological analysis of MSA patients.
  • Review of current pharmacological treatments for motor and autonomic features.
  • Analysis of research initiatives addressing unmet needs in MSA.

Main Results:

  • Motor features in MSA have disappointing treatment outcomes, with only transient L-Dopa response in some MSA-P patients.
  • Autonomic and urogenital features of MSA can be effectively treated if identified early.
  • Significant disability and progressive nature of MSA necessitate further research.

Conclusions:

  • Early identification and management of autonomic/urogenital symptoms are vital for improving MSA patient outcomes.
  • Current treatments for motor symptoms are largely ineffective, highlighting a critical unmet need.
  • Collaborative research efforts are essential to advance understanding and treatment of this devastating disorder.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...